Liquid Biopsy Labs

Liquid Biopsy Labs is a Canadian precision oncology diagnostics company focused on liquid biopsy and tissue-based next-generation sequencing for early cancer detection, molecular profiling, and treatment monitoring. The company offers personalized ctDNA testing, exosomal RNA-based liquid biopsy, tumor DNA sequencing, and tumor RNA sequencing services for patients, physicians, researchers, and clinical facilities. Its core differentiation is an exosome-based L-RNA assay and broad DNA/RNA sequencing designed to identify actionable cancer-related molecular changes with high sensitivity. Liquid Biopsy Labs appears to operate as a commercial testing and services business rather than a therapeutics developer, with offerings aimed at cancer detection, monitoring, and precision treatment support.